Sequenom Lowers Full-Year Revenue Estimate | GenomeWeb

NEW YORK (GenomeWeb) – Sequenom said today that its second-half 2015 revenues will be lower than previously anticipated and has accordingly dropped its full-year revenue guidance to a range of 15 percent to 23 percent lower than its previous estimate of $150 million to $170 million.

The firm expects second-half 2015 revenues to be in the range of $57 million to $61 million and full-year revenues to be between $127 million and $131 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.